Effects of the histamine H1 receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward

European Journal of Pharmacology

Volumn 683, Issue 1-3, 2012, Pages 161-165

  Oleson, Erik B ^a   Ferris, Mark J ^a   España, Rodrigo A ^a   Harp, Jill ^a   Jones, Sara R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Agonist therapy; Antihistamine; Benztropine; Dopamine; Psychostimulant; Reward

Indexed keywords

BENZATROPINE; COCAINE; DIPHENYLPYRALINE; DOPAMINE; DOPAMINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOPAMINE UPTAKE; DOSE TIME EFFECT RELATION; IN VIVO STUDY; INHIBITION KINETICS; LOCOMOTION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REWARD;

ANIMALS; BEHAVIOR, ANIMAL; BENZTROPINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE UPTAKE INHIBITORS; EXPLORATORY BEHAVIOR; HISTAMINE H1 ANTAGONISTS; KINETICS; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PIPERIDINES; PSYCHOMOTOR AGITATION; REWARD; SPATIAL BEHAVIOR; STREET DRUGS;

EID: 84860494025     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.03.003     Document Type: Article

References (49)

1. M.L. Banks, M.L. Andersen, K.S. Murnane, R.C. Meyer, and L.L. Howell Behavioral and neurochemical effects of cocaine and diphenhydramine combinations in rhesus monkeys Psychopharmacology (Berl) 205 2009 467 474
2. K.C. Berridge, and T.E. Robinson Parsing reward Trends Neurosci. 26 2003 507 513
3. J.T. Coyle, and S.H. Snyder Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action Science 166 1969 899 901
4. G. Di Chiara, and A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc. Natl. Acad. Sci. U. S. A. 85 1988 5274 5278
5. H.C. Dringenberg, M.A. de Souza-Silva, R.K. Schwarting, and J.P. Huston Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade Naunyn Schmiedebergs Arch. Pharmacol. 358 1998 423 429
6. L.O. Farnebo, K. Fuxe, B. Hamberger, and H. Ljungdahl Effect of some antiparkinsonian drugs on catecholamine neurons J. Pharm. Pharmacol. 22 1970 733 737
7. B.A. Fischer, and D.L. Boggs The role of antihistaminic effects in the misuse of quetiapine: a case report and review of the literature Neurosci. Biobehav. Rev. 34 2010 555 558
8. P.A. Garris, E.A. Budygin, P.E. Phillips, B.J. Venton, D.L. Robinson, B.P. Bergstrom, G.V. Rebec, and R.M. Wightman A role for presynaptic mechanisms in the actions of nomifensine and haloperidol Neuroscience 118 2003 819 829
9. J. Grabowski, J. Shearer, J. Merrill, and S.S. Negus Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence Addict. Behav. 29 2004 1439 1464
10. A.G. Halpert, M.C. Olmstead, and R.J. Beninger Mechanisms and abuse liability of the anti-histamine dimenhydrinate Neurosci. Biobehav. Rev. 26 2002 61 67
11. C. Hasegawa, T. Kumazawa, X.P. Lee, M. Fujishiro, A. Kuriki, A. Marumo, H. Seno, and K. Sato Simultaneous determination of ten antihistamine drugs in human plasma using pipette tip solid-phase extraction and gas chromatography/mass spectrometry Rapid Commun. Mass Spectrom. 20 2006 537 543
12. D.V. Herin, C.V. Rush, and J. Grabowski Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies Ann. N. Y. Acad. Sci. 1187 2010 76 100
13. I. Hindmarch, and Z. Shamsi Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects Clin. Exp. Allergy. 3 1999 133 142
14. T. Hiranita, P.L. Soto, A.H. Newman, and J.L. Katz Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors J. Pharmacol. Exp. Ther. 329 2009 677
15. L.L. Howell, and K.M. Wilcox The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates J Pharmacol. Exp. Ther. 298 2001 1 6
16. P.W. Kalivas, and P. Duffy Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals J. Neurosci. 13 1993 266 275
17. J.L. Katz, S. Izenwasser, R.H. Kline, A.C. Allen, and A.H. Newman Novel 3-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine Journal of Pharmacology and Experimental Therapeutics 288 1999 302
18. G.G. Kay The effects of antihistamines on cognition and performance J. Allergy Clin. Immunol. 105 2000 S622 S627
19. T.M. Korotkova, H.L. Haas, and R.E. Brown Histamine excites GABAergic cells in the rat substantia nigra and ventral tegmental area in vitro Neuroscience letters. 320 2002 133 136
20. G.B. Lapa, G.D. Byrd, A.A. Lapa, E.A. Budygin, S.R. Childers, S.R. Jones, and J.J. Harp The synthesis and biological evaluation of dopamine transporter inhibiting activity of substituted diphenylmethoxypiperidines Bioorg. Med. Chem. Lett. 15 2005 4915 4918
21. G.B. Lapa, T.A. Mathews, J. Harp, E.A. Budygin, and S.R. Jones Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties Eur. J. Pharmacol. 506 2005 237 240
22. K. Matsunaga, T. Sato, H. Shuto, Y. Tsuruta, K. Suemaru, Y. Gomita, and R. Oishi Inhibition of neuronal dopamine uptake by some antiallergic drugs Eur. J. Pharmacol. 350 1998 165 169
23. M.E. Mooney, D.V. Herin, J.M. Schmitz, N. Moukaddam, C.E. Green, and J. Grabowski Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial Drug Alcohol Depend. 101 2009 34 41
24. M.A. Morency, and R.J. Beninger Dopaminergic substrates of cocaine-induced place conditioning Brain Res. 399 1986 33 41
25. M.A. Nader, K.A. Grant, H.M.L. Davies, R.H. Mach, and S.R. Childers The reinforcing and discriminative stimulus effects of the novel cocaine analog 2-propanoyl-3-(4-tolyl)-tropane in rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 280 1997 541
26. A.H. Newman, and G.E. Agoston Novel benztropine [3a-(diphenylmethoxy) tropane] analogs as probes for the dopamine transporter Curr. Med. Chem. 5 1998 305 319
27. A.N. Nicholson, P.A. Pascoe, C. Turner, C.R. Ganellin, P.M. Greengrass, A.F. Casy, and A.D. Mercer Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene Br. J. Pharmacol. 104 1991 270 276
28. G.G. Nomikos, and C. Spyraki Cocaine-induced place conditioning: importance of route of administration and other procedural variables Psychopharmacology (Berl) 94 1988 119 125
29. T. Ohno, S. Kobayashi, M. Hayashi, M. Sakurai, and I. Kanazawa Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients J. Neurol. Sci. 182 2001 95 97
30. E.B. Oleson, J. Salek, K.D. Bonin, S.R. Jones, and E.A. Budygin Real-time voltammetric detection of cocaine-induced dopamine changes in the striatum of freely moving mice Neurosci. Lett. 467 2009 144 146
31. D.M. Platt, J.K. Rowlett, and R.D. Spealman Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development Psychopharmacology (Berl) 163 2002 265 282
32. H. Puhakka, T. Rantanen, and E. Virolainen Diphenylpyraline (Lergobine) in the treatment of patients suffering from allergic and vasomotor rhinitis J. Int. Med. Res. 5 1977 37 41
33. T.T. Quach, A.M. Duchemin, C. Rose, and J.C. Schwartz In vivo occupation of cerebral histamine H1-receptors evaluated with 3H-mepyramine may predict sedative properties of psychotropic drugs Eur. J. Pharmacol. 60 1979 391 392
34. R.B. Rothman High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development Life Sci. 46 1990 PL17 PL21
35. R.B. Rothman, M.H. Baumann, T.E. Prisinzano, and A.H. Newman Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction Biochem. Pharmacol. 75 2008 2 16
36. J. Sabeti, G.A. Gerhardt, and N.R. Zahniser Chloral hydrate and ethanol, but not urethane, alter the clearance of exogenous dopamine recorded by chronoamperometry in striatum of unrestrained rats Neurosci. Lett. 343 2003 9 12
37. J. Shearer The principles of agonist pharmacotherapy for psychostimulant dependence Drug Alcohol Rev. 27 2008 301 308
38. F.E. Simons Advances in H1-antihistamines N. Engl. J. Med. 351 2004 2203 2217
39. J.W. Slater, A.D. Zechnich, and D.G. Haxby Second-generation antihistamines: a comparative review Drugs 57 1999 31 47
40. T. Suzuki, T. Mori, M. Tsuji, M. Nomura, M. Misawa, and K. Onodera Evaluation of the histamine H1-antagonist-induced place preference in rats Jpn. J. Pharmacol. 81 1999 332 338
41. G. Tanda, T.A. Kopajtic, and J.L. Katz Cocaine-like neurochemical effects of antihistaminic medications J. Neurochem. 106 2008 147 157
42. G. Tanda, A.H. Newman, and J.L. Katz Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors Adv. Pharmacol. 57 2009 253 289
43. E.M. Unterwald, L.T. Kucharski, J.E. Williams, and C. Kornetsky Tripelennamine: enhancement of brain-stimulation reward Life Sci. 34 1984 149 153
44. Z. Wang, and W.L. Woolverton Super-additive interaction of the reinforcing effects of cocaine and H1-antihistamines in rhesus monkeys Pharmacol. Biochem. Behav. 91 2009 590 595
45. A. Wauquier, and C.J. Niemegeers Effects of chlorpheniramine, pyrilamine and astemizole on intracranial self-stimulation in rats Eur. J. Pharmacol. 72 1981 245 248
46. D.S. Wishart, C. Knox, A.C. Guo, D. Cheng, S. Shrivastava, D. Tzur, B. Gautam, and M. Hassanali DrugBank: a knowledgebase for drugs, drug actions and drug targets Nucleic Acids Res. 36 2008 D901 D906
47. Q. Wu, M.E. Reith, R.M. Wightman, K.T. Kawagoe, and P.A. Garris Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry J. Neurosci. Methods 112 2001 119 133
48. J.T. Yorgason, S.R. Jones, and R.A. Espana Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection Neuroscience 182 2011 125 132
49. P. Zimmermann, C. Privou, and J.P. Huston Differential sensitivity of the caudal and rostral nucleus accumbens to the rewarding effects of a H1-histaminergic receptor blocker as measured with place-preference and self-stimulation behavior Neuroscience 94 1999 93 103